Advocacy intelligence hub — real-time data for patient organizations
Paul Szabolcs — PHASE1, PHASE2
National Institute of Allergy and Infectious Diseases (NIAID)
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Gamimune N
(Immune globulin intravenous, human)Orphan drugstandardBayer Corporation
Human Immunoglobulin G [EPC]
12.1 Mechanism of Action BIVIGAM is a replacement therapy in patients with primary humoral immunodeficiency (PI) (e.g. agammaglobulinaemia, hypogammag...
Donald B. Kohn, MD, D.D.S
University of California, Los Angeles
📍 NEW HAVEN, CT
Paul Szabolcs, MD
UPMC Children's Hospital of Pittsburgh
📍 Pittsburgh, Pennsylvania
Ewelina Mamcarz, MD, MD
St. Jude Children's Research Hospital
📍 MEMPHIS, TN
Stephen Gottschalk, MD, MD
Baylor College of Medicine
📍 MEMPHIS, TN
Mitchell S Cairo, MD, MD
New York Medical College
📍 HAWTHORNE, NY
Joel Moss, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
📍 Bethesda, Maryland